NCT04144439RecruitingPhase 4
Effect of GABA on ADHD and Seizures in Children With Epilepsy.
Effect of Gamma Aminobutyric Acid on ADHD and Seizures in Children With Epilepsy.
Source: ClinicalTrials.gov · Last updated 30 Oct 2019 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Effect of GABA on ADHD and seizures in Children with epilepsy.
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 4 Oct 2019
- Start date
- 1 Jul 2018
- Primary completion date
- 1 Dec 2028
- Lead sponsor
- Sherief Abd-Elsalam
- Diseases
- Epilepsy
- NCT number
- NCT04144439
What you commit to
- Study type: Interventional · Phase 4
- Planned participants: 30
- From 1 Jul 2018 to the primary completion date, 1 Dec 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Epilepsy without ADHD
Who the study is looking for
- Epilepsy
- ADHD
Age in the registry: 4 years to 18 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sherief Abd-Elsalam Coordinator of this site? Confirm its status | Tanta | Egypt | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.